Circulating levels of FGF21, a potent insulin sensitizer and metabolism regulator, are elevated in mouse models of obesity although obese mice still respond to high doses of FGF21 by ameliorating glucose and lipid parameters (reviewed in20). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.